NasdaqGS - Nasdaq Real Time Price USD
Aclaris Therapeutics, Inc. (ACRS)
At close: November 15 at 4:00 PM EST
Pre-Market: 8:24 AM EST
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-17,898.0000
-78,325.0000
-67,567.0000
-52,134.0000
-38,633.0000
Investing Cash Flow
26,504.0000
46,220.0000
12,628.0000
-167,632.0000
6,387.0000
Financing Cash Flow
5.0000
26,706.0000
72,867.0000
225,052.0000
18,372.0000
End Cash Position
47,651.0000
39,878.0000
45,277.0000
27,349.0000
22,063.0000
Capital Expenditure
-562.0000
-1,309.0000
-605.0000
-308.0000
-453.0000
Issuance of Capital Stock
--
26,714.0000
72,744.0000
238,200.0000
7,737.0000
Issuance of Debt
--
--
--
--
10,913.0000
Repayment of Debt
--
--
--
-11,483.0000
-137.0000
Free Cash Flow
-18,460.0000
-79,634.0000
-68,172.0000
-52,442.0000
-39,086.0000
12/31/2020 - 10/6/2015
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
MYNZ Mainz Biomed N.V.
0.2387
-4.52%
STIM Neuronetics, Inc.
0.7100
-10.13%
NOTV Inotiv, Inc.
2.6800
-1.83%
NDRA ENDRA Life Sciences Inc.
4.5400
-14.34%
PRE Prenetics Global Limited
4.5000
-5.26%
ENZ Enzo Biochem, Inc.
1.0400
0.00%
GENE Genetic Technologies Limited
0.7650
0.00%
PSNL Personalis, Inc.
3.8900
-9.53%
VCYT Veracyte, Inc.
35.94
-2.97%
PRPO Precipio, Inc.
6.19
-0.77%